RHOA and pulmonary hypertension: Activation of RhoA and its downstream mediator Rho-associated kinase is implicated in the pathogenesis of pulmonary hypertension (PH) and inhibition of the RhoA/Rho-kinase may also contribute to the beneficial effects of established therapies, such as sildenafil [5-8].